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Summary and Implications 
The catalytic mechanism of metmyoglobin (metMb) on 
the development of lipid oxidation in a phospholipid 
liposome model system was studied. Liposome model 
system was prepared with metMb solutions (2.0, 1.0, 0.5, 
and 0.25 mg metMb / mL) containing none, 
diethylenetriamine pentaacetic acid (DTPA), 
desferrioxamine (DFO), or ferric chloride and lipid 
oxidation was determined at 0, 15, 30, 60, and 90 min of 
incubation at 37 °C. Metmyoglobin catalyzed lipid 
oxidation in the liposome system, but the rate of lipid 
oxidation decreased as the concentration of metMb 
increased. The amount of free ionic iron in the liposome 
solution increased as the concentration of metMb increased, 
but the rate of metMb degradation was increased as the 
concentration of metMb decreased. The released free ionic 
iron was not involved in the lipid oxidation of model system 
because ferric iron has no catalytic effect without reducing 
agents. Both DFO and DTPA showed antioxidant effects, 
but DFO was more efficient than DTPA because of its 
multifunctional antioxidant ability as an iron and hematin 
chelator and an electron donor. The antioxidant activity of 
DTPA in liposome solution containing 0.25 mg metMb/mL 
was two times greater than that with 2 mg metMb/mL due 
to the increased prooxidant activity of DTPA-chelatable 
compounds. It was concluded that ferrylmyoglobin and 
DTPA-chelatable hematin generated from the interaction of 
metMb and LOOH, rather than free ionic iron, were the 
major catalysts in metMb-induced lipid oxidation in 
phospholipid liposome model system. 
 
Introduction 
It has been suggested that the interaction of 
metmyoglobin (metMb) with hydrogen peroxide (H2O2) or 
lipid hydroperoxides (LOOH) results in the formation of 
ferrylmyoglobin, which can initiate free radical chain 
reactions. In addition, ferrylmyoglobin as well as metMb 
can degrade LOOH to free radicals such as alkoxyl and 
peroxyl radicals, which can initiate and/or catalyze a series 
of propagation and termination step in the free radical chain 
reactions of lipid oxidation. However, others limited the role 
of myoglobin as only a source for free ionic iron or hematin. 
The ratio of peroxides to metMb is a determining factor for 
the formation of ferrylmyoglobin or the release of free ionic 
iron or hematin. Hematin is released from myoglobin in the 
presence of H2O2, followed by the liberation of free ionic 
iron from hematin. Hematin reacts with H2O2 or lipid 
hydroperoxide to form hematin with higher oxidation state 
(Ferrylhematin, Fe(IV=O)), which can initiate and 
propagate lipid oxidation. The concentration of metMb is a 
determining factor for its prooxidative activity in the 
presence of fatty acid or LOOH. In addition, myoglobin 
shows a pseudo-hydroperoxidase activity in the presence of 
reducing agents such as ascorbic acid and phenolic 
antioxidants to remove lipid hydroperoxides. 
Iron chelators such as diethylenetriamine pentaacetic 
acid (DTPA) and desferrioxamine (DFO) have been widely 
used to elucidate the mechanism of iron compounds on lipid 
oxidation. DFO has been known as an excellent chelating 
agent for ferric ion and DTPA for ferrous and ferric ions. 
Both DFO and DTPA have chelating ability to hematin. 
DFO can also act as an electron donor to ferrylmyoglobin to 
suppress the prooxidant activity of ferrylmyoglobin and 
release free ionic iron from metMb as well as to free 
radicals to break down the free radical chain reaction of 
lipid oxidation.  
The objectives of this study were to determine the 
concentration effect of metMb and the effect of ferric ion 
and chelators such as DFO and DTPA on the metMb-
induced lipid oxidation in the phospholipid liposome model 
system.  
 
Materials and Methods 
The metMb-liposome model system was prepared using 
phospholipids. The metMb solution containing none, DTPA, 
DFO, or ferric chloride was added to a metMb-liposome 
solution and lipid oxidation was determined. In addition, the 
generation of nonheme iron during the incubation was 
measured using the ferrozine method. Lipoxygenase-like 
(LOX-like) activity of metMb was measured and the results 
were expressed as units of activity (U) per mL.  
 
Results and Discussion 
Metmyoglobin induced lipid oxidation and increased 
the TBARS values linearly in phospholipid liposome model 
system during the 90 min-incubation (Figure 1). However, 
the increasing rate of TBARS values significantly decreased 
with the increase of metMb concentration. The presence of 
LOOH was detected right after the preparation of the 
liposome model system. This result indicates that the 
concentration of metMb is a critical factor for determining 
prooxidant activity of myoglobin in the presence of LOOH 
and/or fatty acid. 
The amount of free ionic iron significantly increased 
during incubation, and was proportional to the concentration 
of metMb (Figure 2). These results suggested that the 
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interaction of H2O2 or LOOH with metMb caused the 
liberation of free ionic iron as well as hematin. Thus, the 
LOOH preexisted or generated during the incubation should 
be the major catalysts to release free ionic irons from 
metMb because H2O2 was not added in this study.  The 
addition of ferric ion did not affect myoglobin-catalyzed 
lipid oxidation in phospholipid liposome model system 
(Figure 3), indicating that either ferrylmyoglobin or hematin 
generated from metMb rather than free ionic iron was the 
major catalyst for metMb-induced lipid oxidation in this 
system.  
Iron chelators, DTPA and DFO, showed different 
antioxidant effects in the liposome model system (Figure 3). 
DFO inhibited myoglobin-catalyzed lipid oxidation 
effectively, but DTPA showed only partial inhibitions. 
However, DFO showed stronger antioxidant activity than 
DTPA. The antioxidant activity of DTPA was affected by 
the ratio of DTPA to free ionic iron, but DFO was not. DFO 
can act not only as an efficient iron chelator but also an 
electron donor or hydrogen donor to ferrylmyoglobin, 
resulting in the suppression of ferrylmyoglobin-catalyzed 
lipid oxidation. The antioxidant activity of DTPA in 
liposome model system with low concentration of metMb 
(0.25 mg/mL) was twice as high as that with high 
concentration (Figures 3A and 3B), indicating that DTPA-
chelatable compound was contributed more to the 
development of lipid oxidation at lower than at higher 
concentration of metMb.  
LOX-like activity is related to the generation of 
conjugated diene at initial stage of lipid oxidation. LOX-like 
activity of metMb was not changed by ferric ion in the 
absence of reducing agents (Figure 4), indicating that free 
ionic ion released from myoglobin was not involved in the 
initiation of lipid oxidation in metMb-induced lipid 
oxidation. The addition of DFO and DTPA to the liposome 
model system decreased LOX-like activity of metMb, but 
DTPA suppressed it more effectively than DFO.  
 In this study, the catalytic mechanism of metMb on 
lipid oxidation was investigated in phospholipid liposome 
solutions incubated at 37 ºC, which is different from the 
refrigerated temperature conditions (4 ºC) for normal meat 
storage and distribution. In general, the reaction rates 
increase as the reaction temperature increase. Although 
temperature at or below 37 ºC is not likely to change the 
nature of metMb, it may affect the reactivity and/or 
solubility of metMb and other compounds such as lipids and 
hematin. In addition, meat products contain various anti- 
and prooxidative factors.  
 
Figure 1. Lipid oxidation potential of metMb with 
various concentrations in phospholipid liposome model 
system during incubation at 37 °C for 90 min (TBARS: 
mmol malondialdehyde (MDA) equivalents/kg 
phospholipid (PL)). The concentrations of metMb in 50 
mM acetate buffer (pH 5.6) were 2 (Mb2.0), 1 (Mb1.0), 
0.5 (Mb0.5), and 0.25 (Mb0.25) mg per mL, respectively. 
Phospholipid liposome model system with buffer alone 
was used as a control (PL).  
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Figure 2. Formation of nonheme iron in a phospholipid 
liposome model system with various concentrations of 
metMb during incubation at 37 °C for 90 min (μg 
nonheme iron/mL metMb-liposome solution). The 
concentrations of metMb in 50 mM acetate buffer (pH 
5.6) were 2 (Mb2.0), 1 (Mb1.0), 0.5 (Mb0.5), and 0.25 
(Mb0.25) mg per mL, respectively. Phospholipid 
liposome model system with buffer alone was used as a 
control (PL).  
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Figure 3. Lipid oxidation potential of metMb treated with desferrioxamine (DFO, 2 mM; final concentration), 
diethylenetriamine pentaacetic acid (DTPA, 2 mM; final concentration), or ferric chloride (Fe(III), 5 μg/mL; final 
concentration) in phospholipid liposome model system during incubation at 37 °C for 90 min (TBARS value, mmol 
malondialdehyde (MDA) equivalents/kg phospholipid (PL)). The final concentrations of metMb in liposome solution 
were 0.25 (A) and 1.0 (B) mg per mL, respectively. Phospholipid liposome model system with metMb and buffer were 
used as a control (Mb) and blank control (PL), respectively.  
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Figure 4. Lipoxygenase-like activity (Unit/mL) of metMb solution treated with none (control), metMb (1 mg/mL; final 
concentration) desferrioxamine (DFO, 2 mM; final concentration), diethylenetriamine pentaacetic acid (DTPA, 2 
mM; final concentration), or ferric chloride (Fe(III), 5 μg/mL; final concentration) in 50 mM acetate buffer, pH 5.6.   
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